Neurofibromatosis

Neurofibromatosis is a genetic condition in which tumors form on the nerves of the inner ear and cause loss of hearing and balance. Tumors may also occur in the brain and on nerves in the skull and spinal cord, and may cause loss of speech, eye movement, and the ability to swallow. Also called acoustic neurofibromatosis and NF2.

Overview

Feature Articles

Latest Neurofibromatosis News and Research

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Epilepsy drug prevents brain tumor formation and growth in mouse models of NF1

Epilepsy drug prevents brain tumor formation and growth in mouse models of NF1

Vosoritide's first phase 2 study shows increased growth in children with hypochondroplasia

Vosoritide's first phase 2 study shows increased growth in children with hypochondroplasia

Certain progestogens linked to higher brain tumor risk in women, study suggests

Certain progestogens linked to higher brain tumor risk in women, study suggests

Researchers identify increased brain tumor risk with specific contraceptive use

Researchers identify increased brain tumor risk with specific contraceptive use

Combination drug treatment could be effective against malignant peripheral nerve sheath tumors

Combination drug treatment could be effective against malignant peripheral nerve sheath tumors

Does tinnitus cause hearing loss in normal hearing individuals?

Does tinnitus cause hearing loss in normal hearing individuals?

New drug combination may improve treatment for rare nerve sheath tumors

New drug combination may improve treatment for rare nerve sheath tumors

Exploring developmental pathways and disease interactions in nervous and stomatognathic systems

Exploring developmental pathways and disease interactions in nervous and stomatognathic systems

Renowned innovator in robotic surgery named as new chair of the Department of Otolaryngology—Head and Neck Surgery at NYU Langone

Renowned innovator in robotic surgery named as new chair of the Department of Otolaryngology—Head and Neck Surgery at NYU Langone

World's largest gathering of NF community convenes in Arizona to advance research and care

World's largest gathering of NF community convenes in Arizona to advance research and care

AI algorithms for rare disease diagnosis ignore the genetic, morphological diversity of humans

AI algorithms for rare disease diagnosis ignore the genetic, morphological diversity of humans

Study shows effectiveness, safety of stereotactic radiosurgery for NF2-related vestibular schwannomas

Study shows effectiveness, safety of stereotactic radiosurgery for NF2-related vestibular schwannomas

Unexpected discovery may lead to improved treatments for YAP fusion-driven cancers

Unexpected discovery may lead to improved treatments for YAP fusion-driven cancers

Distinct genomic patterns of malignant peripheral nerve sheath tumors may help with early diagnosis

Distinct genomic patterns of malignant peripheral nerve sheath tumors may help with early diagnosis

Study to determine if a DNA-based blood test can help detect cancer predisposition in NF1 patients

Study to determine if a DNA-based blood test can help detect cancer predisposition in NF1 patients

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

Parents become drug developers to save their children’s lives

Parents become drug developers to save their children’s lives

Epilepsy drug inhibits the growth of NF1 tumors in mice

Epilepsy drug inhibits the growth of NF1 tumors in mice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.